SCHEMBL4478017

SCHEMBL4478017

Cc1cc(C)c2c(C#N)c(/C=C/C(=O)O)n([C@@H]3CCCc4ccccc43)c2n1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.36
PDE7B Q9NP56 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.34
HSD11B1 P28845 1/20 0.34
CD38 P28907 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 4/20 0.33
USP2 O75604 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
MAOB P27338 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
AADAT Q8N5Z0 1/20 0.32
CMA1 P23946 1/20 0.32
NTRK1 P04629 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4479225 1.00 PDE7A (0.36) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4479230 1.00 PDE7A (0.36) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4474586 1.00 PDE7A (0.36) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4474583 1.00 PDE7A (0.36) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4478024 1.00 PDE7A (0.36) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4478347 0.95 CMA1 (0.36) ALDH1A1KDM4EHPGDMAPTCMA1
SCHEMBL4478355 0.95 CMA1 (0.36) ALDH1A1KDM4EHPGDMAPTCMA1
SCHEMBL4488946 0.90 ALDH1A1 (0.37) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4488938 0.90 ALDH1A1 (0.37) PDE7APDE7BALDH1A1KDM4EHSD11B1
SCHEMBL4475604 0.90 KMT2A (0.37) ALDH1A1KDM4ECD38SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582651-B2 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-01 US disclosed
US-20060167038-A1 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-07-27 US disclosed
EP-1535922-A1 PYRROLOPYRIDINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167038-A1 Pyrrolopyridine derivative and use thereof OPRD1, TRPV1, OPRM1 PDE7A 824/4885PDE7B 1528/4885ALDH1A1 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.